GC Pharma

About us
- Our Culture
  
  Mission & Vision
  
  Core Value
  
  Responsibility
- Our People
  
  Leaders
  
  Board of Directors

R&D

Immunization against tetanus and 
diphtheria is required by law under the 
National Immunization Program in S.Korea.

Products
- I.V.-Globulin SN inj.
  Human normal immunoglobulin G & Colorless transparent liquid formulation
- Albumin inj.-GCC
  Normal Human Serum Albumin, Solution for Intravenous Injection
- GC FLU pre-filled syringe inj.
  Pre-filled syringe injections & Influenza vaccine (split virion, inactivated)
- GreenGene F inj.
  Blood coagulation factor VIII, recombinant & White or light yellow powder, odorless, colorless and transparent vials
- Products
  
  Plasma Derivatives
  
  Vaccines
  
  Prescription Drugs
  
  Over-the-counter Drugs
- Product Search
Investors
Green Cross

152,000 KRW

4,500 3.05%

Green Cross Holdings

26,250 KRW

50 0.19%
- Financial Highlights
- Detailed Share Price
  
  Real-time Quotes
  
  Financial Index
  
  Daily Quotes
- Quarterly Results
  
  Financial Statements
  
  Shareholders
  
  Dividend Information
- Presentations

Search

Keyword Search: Plasma Derivatives Office Vaccines Subsidiary Pipeline R&D Media Stock Company Recruit

Product Search

About us
R&D
Products
- Products
Investors
Newsroom
- Press Release
Careers
Contact us
- Inquiry

KOR

InvestorsFinancial Statements